National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Everolimus (Votubia®) for the treatment of patients aged 3 years and older with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC) who require therapeutic intervention but are not amenable to surgery

Rapid Review

Commenced Completed Outcome
30/09/2011 14/10/2011 Full Pharmacoeconomic Evaluation Recommended

The company has not submitted a HTA dossier to the NCPE therefore the cost effectiveness of the technology could not be proven.